1
|
Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry.
|
Nature
|
2002
|
5.48
|
2
|
Hitting hotspots: spatial targeting of malaria for control and elimination.
|
PLoS Med
|
2012
|
4.68
|
3
|
Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection.
|
Am J Trop Med Hyg
|
2007
|
4.20
|
4
|
High efficiency transfection of Plasmodium berghei facilitates novel selection procedures.
|
Mol Biochem Parasitol
|
2005
|
3.95
|
5
|
Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum.
|
J Infect Dis
|
2006
|
3.17
|
6
|
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.
|
Lancet
|
2011
|
2.98
|
7
|
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites.
|
J Biol Chem
|
2003
|
2.84
|
8
|
Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya.
|
Malar J
|
2004
|
2.84
|
9
|
Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania.
|
Trop Med Int Health
|
2007
|
2.69
|
10
|
The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion.
|
Trends Parasitol
|
2006
|
2.53
|
11
|
Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.
|
Proc Natl Acad Sci U S A
|
2005
|
2.49
|
12
|
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
|
PLoS One
|
2009
|
2.49
|
13
|
Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.
|
PLoS One
|
2009
|
2.18
|
14
|
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
|
Antimicrob Agents Chemother
|
2010
|
2.15
|
15
|
The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system.
|
Science
|
2013
|
2.15
|
16
|
Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity.
|
PLoS Pathog
|
2008
|
1.98
|
17
|
Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility.
|
PLoS Pathog
|
2010
|
1.72
|
18
|
Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.
|
Am J Trop Med Hyg
|
2004
|
1.65
|
19
|
No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria.
|
Trans R Soc Trop Med Hyg
|
2006
|
1.64
|
20
|
Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice.
|
Proc Natl Acad Sci U S A
|
2008
|
1.64
|
21
|
Comparison of clinical and parasitological data from controlled human malaria infection trials.
|
PLoS One
|
2012
|
1.64
|
22
|
Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection.
|
J Infect Dis
|
2009
|
1.63
|
23
|
Plasmodium falciparum infection causes proinflammatory priming of human TLR responses.
|
J Immunol
|
2007
|
1.63
|
24
|
Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites.
|
Am J Trop Med Hyg
|
2012
|
1.62
|
25
|
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
|
J Infect Dis
|
2013
|
1.61
|
26
|
Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.
|
Proc Natl Acad Sci U S A
|
2013
|
1.57
|
27
|
Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers.
|
J Infect Dis
|
2012
|
1.54
|
28
|
Dynamic histone H3 epigenome marking during the intraerythrocytic cycle of Plasmodium falciparum.
|
Proc Natl Acad Sci U S A
|
2009
|
1.54
|
29
|
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.
|
J Infect Dis
|
2013
|
1.52
|
30
|
Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans.
|
PLoS Pathog
|
2011
|
1.51
|
31
|
Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria.
|
J Leukoc Biol
|
2010
|
1.51
|
32
|
Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
|
Trop Med Int Health
|
2005
|
1.46
|
33
|
Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria.
|
J Infect Dis
|
2007
|
1.42
|
34
|
Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum.
|
Mol Biochem Parasitol
|
2006
|
1.42
|
35
|
Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae.
|
Am J Trop Med Hyg
|
2008
|
1.35
|
36
|
Age-dependent distribution of Plasmodium falciparum gametocytes quantified by Pfs25 real-time QT-NASBA in a cross-sectional study in Burkina Faso.
|
Am J Trop Med Hyg
|
2007
|
1.34
|
37
|
Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production.
|
Mol Microbiol
|
2006
|
1.33
|
38
|
The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer.
|
Parasitol Int
|
2009
|
1.32
|
39
|
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
|
Trop Med Int Health
|
2005
|
1.31
|
40
|
HGF/MET signalling protects Plasmodium-infected host cells from apoptosis.
|
Cell Microbiol
|
2005
|
1.28
|
41
|
Responses to malarial antigens are altered in helminth-infected children.
|
J Infect Dis
|
2009
|
1.26
|
42
|
A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines.
|
Vaccine
|
2012
|
1.25
|
43
|
Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
|
PLoS One
|
2008
|
1.25
|
44
|
Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.
|
Cell Microbiol
|
2006
|
1.25
|
45
|
Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites.
|
J Cell Sci
|
2006
|
1.23
|
46
|
Malaria in Wanokaka and Loli sub-districts, West Sumba District, East Nusa Tenggara Province, Indonesia.
|
Am J Trop Med Hyg
|
2006
|
1.20
|
47
|
Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection.
|
Cell Host Microbe
|
2008
|
1.20
|
48
|
A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages.
|
Blood
|
2012
|
1.19
|
49
|
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection.
|
Br J Haematol
|
2009
|
1.19
|
50
|
Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
|
Vaccine
|
2006
|
1.16
|
51
|
Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations.
|
PLoS One
|
2011
|
1.12
|
52
|
Early interferon-gamma response against Plasmodium falciparum correlates with interethnic differences in susceptibility to parasitemia between sympatric Fulani and Dogon in Mali.
|
J Infect Dis
|
2010
|
1.12
|
53
|
Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
|
Vaccine
|
2012
|
1.11
|
54
|
Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum.
|
Eur J Immunol
|
2010
|
1.10
|
55
|
Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia.
|
Am J Trop Med Hyg
|
2006
|
1.09
|
56
|
Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers.
|
PLoS One
|
2011
|
1.08
|
57
|
New approach for high-throughput screening of drug activity on Plasmodium liver stages.
|
Antimicrob Agents Chemother
|
2006
|
1.08
|
58
|
The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays.
|
Sci Rep
|
2013
|
1.07
|
59
|
How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection.
|
Trends Parasitol
|
2013
|
1.07
|
60
|
Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
|
Hum Vaccin
|
2011
|
1.06
|
61
|
Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?
|
Infect Immun
|
2007
|
1.05
|
62
|
Plasmodium liver load following parenteral sporozoite administration in rodents.
|
Vaccine
|
2012
|
1.04
|
63
|
Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy.
|
Br J Haematol
|
2010
|
1.04
|
64
|
Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells.
|
PLoS One
|
2012
|
1.04
|
65
|
Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development.
|
FASEB J
|
2014
|
1.04
|
66
|
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
|
J Infect Dis
|
2012
|
1.04
|
67
|
Seasonal patterns of Plasmodium falciparum gametocyte prevalence and density in a rural population of Burkina Faso.
|
Acta Trop
|
2007
|
1.02
|
68
|
A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum.
|
Clin Vaccine Immunol
|
2011
|
1.01
|
69
|
Liver or blood-stage arrest during malaria sporozoite immunization: the later the better?
|
Trends Parasitol
|
2013
|
1.00
|
70
|
Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes.
|
Eukaryot Cell
|
2013
|
0.98
|
71
|
Transmission of Plasmodium falciparum in urban Yaoundé, Cameroon, is seasonal and age-dependent.
|
Trans R Soc Trop Med Hyg
|
2004
|
0.98
|
72
|
A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.
|
PLoS One
|
2013
|
0.97
|
73
|
Prevalence and severity of malnutrition in pre-school children in a rural area of western Kenya.
|
Am J Trop Med Hyg
|
2003
|
0.96
|
74
|
Malaria infected mosquitoes express enhanced attraction to human odor.
|
PLoS One
|
2013
|
0.94
|
75
|
Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation.
|
Chem Biol
|
2007
|
0.94
|
76
|
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
|
PLoS One
|
2009
|
0.92
|
77
|
BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.
|
J Immunol
|
2014
|
0.92
|
78
|
Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection.
|
Ann Pharmacother
|
2005
|
0.91
|
79
|
Complement activation in experimental human malaria infection.
|
Trans R Soc Trop Med Hyg
|
2007
|
0.91
|
80
|
Removal of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinase.
|
PLoS One
|
2010
|
0.90
|
81
|
Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera.
|
Int J Parasitol
|
2006
|
0.90
|
82
|
A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.
|
PLoS One
|
2007
|
0.89
|
83
|
Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana.
|
Malar J
|
2005
|
0.88
|
84
|
Efficacy of artemisinin-based combination therapy for treatment of persons with uncomplicated Plasmodium falciparum malaria in West Sumba District, East Nusa Tenggara Province, Indonesia, and genotypic profiles of the parasite.
|
Am J Trop Med Hyg
|
2009
|
0.88
|
85
|
Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice.
|
Malar J
|
2012
|
0.88
|
86
|
Identification of a major rif transcript common to gametocytes and sporozoites of Plasmodium falciparum.
|
Malar J
|
2010
|
0.88
|
87
|
Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia.
|
Malar J
|
2009
|
0.86
|
88
|
A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.
|
Hum Vaccin Immunother
|
2014
|
0.86
|
89
|
Short report: Severe Plasmodium falciparum malaria in Cameroon: associated with the glutathione S-transferase M1 null genotype.
|
Am J Trop Med Hyg
|
2006
|
0.86
|
90
|
Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver.
|
J Immune Based Ther Vaccines
|
2011
|
0.79
|
91
|
Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity.
|
Malar J
|
2014
|
0.79
|
92
|
Common genotypic polymorphisms in glutathione S-transferases in mild and severe falciparum malaria in Tanzanian children.
|
Am J Trop Med Hyg
|
2009
|
0.78
|
93
|
The dog that did not bark: malaria vaccines without antibodies.
|
Trends Parasitol
|
2007
|
0.78
|
94
|
Enhancement of naturally acquired immunity against malaria by drug use.
|
J Med Microbiol
|
2012
|
0.78
|
95
|
Persistence of full-length caspase-12 and its relation to malaria in West and Central African populations.
|
Eur Cytokine Netw
|
2010
|
0.78
|
96
|
Plasmodium berghei Δp52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells.
|
PLoS One
|
2012
|
0.78
|
97
|
Controlled human malaria infection trials: How tandems of trust and control construct scientific knowledge.
|
Soc Stud Sci
|
2016
|
0.77
|
98
|
Influenza virosomes: a flu jab for malaria?
|
Trends Parasitol
|
2008
|
0.77
|
99
|
Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis.
|
Nature
|
2016
|
0.77
|
100
|
[On the way to eradicating malaria].
|
Ned Tijdschr Geneeskd
|
2012
|
0.75
|
101
|
Editorial: Malaria investments and activities: it is now! or never?
|
Trop Med Int Health
|
2002
|
0.75
|
102
|
[Neuroschistosomiasis; an unexpected finding in a Dutch woman].
|
Ned Tijdschr Geneeskd
|
2009
|
0.75
|